The Zacks Building Products-Miscellaneous Industry is currently in the bottom 19% of 246 Zacks industries, and Arcosa ACA may be a stock to avoid in particular. Having a Zacks Rank #5 (Strong Sell), Arcosa lands the Bear of the Day.
Compounding tougher market conditions, the manufacturer of infrastructure-related products and services is facing operational issues. Notably, the Indiana Department of Environmental Management (IDEM) has warned its aggregates division (Arcosa Lightweight) of potential emissions violations.
Reporting fourth-quarter results in early February, Arcosa’s Q4 sales rose 14% to $666.2 million but missed estimates of $694.2 million by 4%.
More concerning, Arcosa reported a net income loss of $7.7 million compared to a profit of $27.1 million in Q4 2023. Adjusted Q4 EPS was at $0.46, although this dropped from $0.68 a year ago and missed expectations of $0.79 by 42%.
Image Source: Zacks Investment Research
Taking away from Arcosa’s appealing growth trajectory is that fiscal 2025 EPS estimates have dropped 13% over the last 30 days from $4.81 to $4.56. Unfortunately, a trend of declining earnings estimate revisions could continue following the company’s eye-catching earnings miss.
Image Source: Zacks Investment Research
Furthermore, while Arcosa’s stock trades at a reasonable 20.1X forward earnings multiple, it's noteworthy that this is above the industry average of 16.8X with some of its notable peers in the space being CRH plc CRH and TopBuild BLD.
Image Source: Zacks Investment Research
As of now, it's unclear if Arcosa can fulfill its lofty earnings expectations with double-digit EPS growth expected in FY25. Unless of course, earnings estimate revisions keep declining, which would signal more downside risk for ACA shares.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Arcosa, Inc. (ACA) : Free Stock Analysis Report
TopBuild Corp. (BLD) : Free Stock Analysis Report
CRH PLC (CRH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.